This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2004 Sep;364(9437):820-1.

doi: 10.1016/S0140-6736(04)16994-8.

Lymph-node-negative oestrogen-receptor-positive breast cancer

Gary K Pansegrau¹, Karen A Gelmon

Affiliations

PMID: 15351171
DOI: 10.1016/S0140-6736(04)16994-8

Comment

Lymph-node-negative oestrogen-receptor-positive breast cancer

Gary K Pansegrau et al. Lancet. 2004 Sep.

. 2004 Sep;364(9437):820-1.

doi: 10.1016/S0140-6736(04)16994-8.

Authors

Gary K Pansegrau¹, Karen A Gelmon

Affiliation

¹ British Columbia Cancer Agency, Vancouver, British Columbia, Canada V5Z 4E6.

PMID: 15351171
DOI: 10.1016/S0140-6736(04)16994-8

No abstract available

PubMed Disclaimer

Comment on

Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials.
Fisher B, Jeong JH, Bryant J, Anderson S, Dignam J, Fisher ER, Wolmark N; National Surgical Adjuvant Breast and Bowel Project randomised clinical trials. Fisher B, et al. Lancet. 2004 Sep 4-10;364(9437):858-68. doi: 10.1016/S0140-6736(04)16981-X. Lancet. 2004. PMID: 15351193 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information